Healthcare already has effective tools including medications for opioid and alcohol use disorder, but they are not being utilized widely enough. One important reason is the stigma that surrounds people with addiction
People with Drug Use Disorders
Resources and information to help you or someone you care about who might have a drug use problem.
Today, NIDA is releasing several new funding opportunity announcements related to the NIH HEAL (Helping to End Addiction Long-term ℠) Initiative.
Ample evidence shows methadone and buprenorphine reduce overdose deaths, prevent the spread of diseases like HIV, and enable people to take back their lives, but there are restrictions on who can prescribe these medications.
Addressing the Socioeconomic Complexities of Addiction—Lessons from the Kensington Neighborhood in Philadelphia
This September, I was invited by Thomas Farley, the Health Commissioner of Philadelphia, to see firsthand how that city is responding to the opioid crisis. We toured Prevention Point, a private non-profit organization providing harm reduction services to Philadelphia and the surrounding area.
Over the past few years, NIDA’s Office of Translational Initiatives and Program Innovations (OTIPI) has used these and other funding mechanisms to help biotech startups develop incredibly innovative technologies that translate addiction science into healthcare and consumer products.
September is National Suicide Prevention Awareness Month. In observance, our two institutes, the National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH), are taking this opportunity to highlight a dimension of the opioid crisis that receives too little attention—the links between opioid use, opioid use disorder (OUD), and suicide.
Common sense and a growing body of research suggest that patients with opioid use disorder (OUD) who receive acute care in an emergency department will be at reduced risk for later overdose if they are initiated on medications to treat their OUD.
Disparities in access to quality treatment play a role in every aspect of health care and health outcomes, and the opioid crisis is no different.
Subscribe to People with Drug Use Disorders
One of the major challenges in health science today is that not enough patients participate in clinical trials and other studies. Without volunteers willing and able to participate in studies testing new treatments or therapeutic approaches for cancer or Alzheimer’s, for example, researchers cannot test their effectiveness.